Drug Type Monoclonal antibody |
Synonyms PcMab-6 |
Target |
Mechanism PODXL inhibitors(Podocalyxin inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pancreatic Cancer | Preclinical | JP | 21 Dec 2023 |